Trial Profile
A double blind, randomised, placebo controlled trial to investigate time-dose-response relationship of benvitimod cream after topical administration in patients with mild and moderate psoriasis vulgaris
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Jan 2016
Price :
$35
*
At a glance
- Drugs Tapinarof (Primary)
- Indications Plaque psoriasis
- Focus Therapeutic Use
- 04 Jan 2016 New trial record
- 28 Dec 2015 Results published in the International Journal of Clinical Pharmacology and Therapeutics